[1] 张惠民,鱼军,白洁,等.西安市下呼吸道感染性疾病患者病原菌分布及耐药性分析[J].临床医学研究与实践,2022,7(27):5-10. DOI:10.19347/j.cnki.2096-1413.202227002.
[2] 张红霞,陈雪.个性化护理对上呼吸道感染患者护理质量的改善作用研究[J].中国医学文摘(耳鼻咽喉科学),2022,37(5):212-214. DOI:10.19617/j.issn1001-1307.2022. 05.212.
[3] Zaidan Noor F, Britt Rachel, Reynoso David, et al. Utilization of methicillin-sensitive/resistant staphylococcus aureus nares screen to decrease vancomycin and linezolid use in hospitalized patients with respiratory infections[J]. Open Forum Infectious Diseases, 2020, 7(Supplement_1):S60-S60. DOI:10.1093/ofid/ofaa439.132.
[4] Luo HJ, Huang XB, Zhong HL, et al. Epidemiological characteristics and phylogenic analysis of human respiratory syncytial virus in patients with respiratory infections during 2011-2016 in southern China[J]. Int J Infect Dis, 2020, 90:5-17. DOI: 10.1016/j.ijid.2019.10.009.
[5] Babaei Zahra, Pouladi Iman, Ashtari Abbass. The prevalence of atypical pneumonia caused by Mycoplasma pneumoniae (P1 gene) in patients with respiratory infections by culture and molecular PCR methods in Tehran, Iran[J]. Jundishapur Journal of Microbiology, 2020, 12(11):74.
[6] 秦玉梅.临床护理路径在无创呼吸机治疗呼吸衰竭护理中的应用及对患者肺功能的影响[J].国际护理学杂志,2021,40(6):1097-1100. DOI:10.3760/cma.j.cn221370- 20190816-00320.
[7] Munteanu AN, Surcel M, Huică RI, et al. Peripheral immune cell markers in children with recurrent respiratory infections in the absence of primary immunodeficiency[J]. Exp Ther Med, 2019, 18(3):1693-1700. DOI: 10.3892/etm.2019.7714.
[8] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.急性上呼吸道感染基层诊疗指南(2018年)[J].中华全科医师杂志,2019,18(5):422-426. DOI:10.3760/cma.j.issn.1671-7368.2019.05.005.
[9] 黄菲菲,赵秋利,沈晓颖,等.成年人健康自我管理能力测评量表条目的初步筛选[J].护理学杂志,2011,26(2):40-42. DOI:10.3870/hlxzz.2011.02.040.
[10] Oğuzülgen IK, Köktürk N, Işikdoğan Z. Turkish validation study of Morisky 8-item medication adherence questionnaire (MMAS-8) in patients with asthma and chronic obstructive pulmonary disease[J]. Tuberk Toraks, 2014, 62(2):101-107. DOI: 10.5578/tt.7401.
[11] Dąbrowska-Leonik N, Bernatowska E, Pac M, et al. Vitamin D deficiency in children with recurrent respiratory infections, with or without immunoglobulin deficiency[J]. Adv Med Sci, 2018, 63(1):173-178. DOI: 10.1016/j.advms.2017.08.001.
[12] Stolte E, Hopman-Rock M, Aartsen MJ, et al. The theory of planned behavior and physical activity change: outcomes of the aging well and healthily intervention program for older adults[J]. J Aging Phys Act, 2017, 25(3):438-445. DOI: 10.1123/japa.2016-0182.
[13] Spathis D, Vlamos P. Diagnosing asthma and chronic obstructive pulmonary disease with machine learning[J]. Health Informatics J, 2019, 25(3):811-827. DOI: 10.1177/1460458217723169.
[14] Halpin DMG, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2021, 203(1):24-36. DOI: 10.1164/rccm.202009-3533SO.
[15] Schoettler N, Strek ME. Recent advances in severe asthma: from phenotypes to personalized medicine[J]. Chest, 2020, 157(3):516-528. DOI: 10.1016/j.chest.2019.10.009.
[16] Terry PD, Dhand R. Inhalation therapy for stable COPD: 20 years of GOLD reports[J]. Adv Ther, 2020, 37(5):1812-1828. DOI: 10.1007/s12325-020-01289-y.
[17] Gray C, Cooke CE, Brandt N. Evolution of the medicare part D medication therapy management program from inception in 2006 to the present[J]. Am Health Drug Benefits, 2019, 12(5):243-251.
[18] Lau CYK, Lok KYW, Tarrant M. Breastfeeding duration and the theory of planned behavior and breastfeeding self-efficacy framework: a systematic review of observational studies[J]. Matern Child Health J, 2018, 22(3):327-342. DOI: 10.1007/s10995-018-2453-x.
[19] Brooks JM, Huck G, Iwanaga K, et al. Towards an integration of the health promotion models of self-determination theory and theory of planned behavior among people with chronic pain[J]. Rehabil Psychol, 2018, 63(4):553-562. DOI: 10.1037/rep0000245.
[20] 陈春燕,谢华文,李太华,等.医护一体化护理模式对COPD合并Ⅱ型呼吸衰竭行无创呼吸机治疗患者的影响[J].齐鲁护理杂志,2021,27(4):49-52. DOI:10.3969/j.issn.1006-7256. 2021.04.017.
[21] Cardinale F, Lombardi E, Rossi O, et al. Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-85[J]. Expert Rev Respir Med, 2020, 14(10):1019-1026. DOI: 10.1080/17476348.2020.1793673.
[22] Vos LM, Bruyndonckx R, Zuithoff NPA, et al. Lower respiratory tract infection in the community: associations between viral aetiology and illness course[J]. Clin Microbiol Infect, 2021, 27(1):96-104. DOI: 10.1016/j.cmi.2020.03.023.
[23] Pasternak G, Lewandowicz-Uszyńska A, Pentoś K. Disorders of humoral immunity in children with IgG subclass deficiency and recurrent respiratory infections[J]. Adv Exp Med Biol, 2018, 1108:99-106. DOI: 10.1007/5584_2018_263.
[24] Lewandowicz-Uszyńska A, Pasternak G, Pentoś K. Immunoglobulin G deficiency in children with recurrent respiratory infections with and without history of allergy[J]. Adv Exp Med Biol, 2021, 1289:63-70. DOI: 10.1007/5584_2020_541.
[25] Kansen HM, Lebbink MA, Mul J, et al. Risk factors for atopic diseases and recurrent respiratory tract infections in children[J]. Pediatr Pulmonol, 2020, 55(11):3168-3179. DOI: 10.1002/ppul.25042.
[26] Tarantino V, Savaia V, D'Agostino R, et al. Bacteriotherapy in children with recurrent upper respiratory tract infections[J]. Eur Rev Med Pharmacol Sci, 2019, 23(1 Suppl):39-43. DOI: 10.26355/eurrev_201903_17347.
[27] 郑素娟,冯彩莲,樊建凤.高龄呼吸道感染患者病原菌检验以及耐药性监测结果分析[J].广州医药,2021,52(6):83-86,96. DOI:10.3969/j.issn.1000-8535.2021.06.018.
|